Błąd cURL: Failed connect to www.viamedica.pl:443; Connection refused
Vol 71, No 2 (2020)
Clinical vignette
Published online: 2020-04-15

open access

Page views 2203
Article views/downloads 844
Get Citation

Connect on Social Media

Connect on Social Media

Difficulties in the diagnosis and treatment of malignant paraganglioma of the urinary bladder

Ewelina Rzepka1, Aleksandra Gilis-Januszewska1, Marta Opalińska12, Anna Sowa-Staszczak12, Alicja Hubalewska-Dydejczyk12
Pubmed: 32293698
Endokrynol Pol 2020;71(2):196-197.

Abstract

Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file

References

  1. Zhai H, Ma X, Nie W, et al. Paraganglioma of the Urinary Bladder: A Series of 22 Cases in a Single Center. Clin Genitourin Cancer. 2017; 15(5): e765–e771.
  2. Asa SL, Ezzat S, Mete O. The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations. J Clin Med. 2018; 7(9).
  3. Janssen I, Chen CC, Millo CM, et al. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2016; 43(10): 1784–1791.
  4. Satapathy S, Mittal BR, Bhansali A. 'Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis'. Clin Endocrinol (Oxf). 2019; 91(6): 718–727.
  5. Botling J, Lamarca A, Bajic D, et al. High-grade progression confers poor survival in pancreatic neuroendocrine tumors. Neuroendocrinology. 2019 [Epub ahead of print].
Błąd cURL: Failed connect to www.viamedica.pl:443; Connection refused